Ligand profile
ZINC143522087
Virtual-screening candidate from ZINC.
Bound to: KP13_04471 — putative hydrolase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC143522087- UniProt (similar protein)
P0A3G3- Tanimoto
- 0.720
- Target protein
- KP13_04471
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 78.9
- −1 ≤ LogP ≤ 5 1.19
- MW ≤ 500 Da 338.4
- LogP ≤ 5 1.19
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 78.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CN(C)c1cccc2c(S(=O)(=O)NCCOCCO)cccc12CN(C)c1cccc2c(S(=O)(=O)NCCOCCO)cccc12
InChI=1S/C16H22N2O4S/c1-18(2)15-7-3-6-14-13(15)5-4-8-16(14)23(20,21)17-9-11-22-12-10-19/h3-8,17,19H,9-12H2,1-2H3InChI=1S/C16H22N2O4S/c1-18(2)15-7-3-6-14-13(15)5-4-8-16(14)23(20,21)17-9-11-22-12-10-19/h3-8,17,19H,9-12H2,1-2H3
FLARTQRXSPPVGN-UHFFFAOYSA-NFLARTQRXSPPVGN-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 8LL
- Homolog
- P0A3G3
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC143522087 →
- ZINC ZINC20 ZINC143522087 →
- UniProt UniProt P0A3G3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC143522087”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04471.
PDB 20
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).